Exercise-induced bronchospasm: evaluation of albuterol aerosol.
Albuterol aerosol was compared with isoproterenol and placebo in a double-blind, cross-over study in 12 asthmatic children. A significant increase in mean peak expiratory flow rate 15 minutes after albuterol inhalation persisted for at least five hours after treatment. Inhalation of albuterol one hour before treadmill exercise inhibited exercise-induced bronchospasm.
D000293:Adolescent; D000336:Aerosols; D000420:Albuterol / Q000008:administration & dosage* / Q000627:therapeutic use; D001794:Blood Pressure; D001986:Bronchial Spasm / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D005082:Physical Exertion; D010919:Placebos; D011674:Pulse; D013147:Spirometry; D013997:Time Factors
D000336:Aerosols; D010919:Placebos; D007545:Isoproterenol; D000420:Albuterol